We are live on ! Find out more
CMRAW

Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027

Delisted

CMRAW was delisted on the 15th of November, 2023.

3 hedge funds and large institutions have $615 invested in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less funds holding

Funds holding: 153 (-12)

97% less capital invested

Capital invested by funds: $24.3K → $615 (-$23.7K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 11

Holders
3
Holders Change
-12
Holders Change %
-80%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LP
1
LMR Partners
United Kingdom
$300
RCM
2
Rivernorth Capital Management
Florida
$225
CS
3
Clear Street
New York
$90 +$2 +100 +0.3%
WAM
4
Warberg Asset Management
Illinois
-$6.51K -300,000 Closed
YCM
5
Yakira Capital Management
Connecticut
-$3.33K -153,500 Closed
TCM
6
Tenor Capital Management
New York
-$3.25K -150,000 Closed
Walleye Capital
7
Walleye Capital
New York
-$1.34K -61,955 Closed
PFM
8
Privium Fund Management
Netherlands
-$922 -42,488 Closed
Citadel Advisors
9
Citadel Advisors
Florida
-$691 -38,401 Closed
Walleye Trading
10
Walleye Trading
New York
-$756 -34,848 Closed
Verition Fund Management
11
Verition Fund Management
Connecticut
-$315 -17,500 Closed
WAM
12
Wolverine Asset Management
Illinois
-$317 -14,637 Closed
GS
13
GTS Securities
New York
-$207 -11,494 Closed
Morgan Stanley
14
Morgan Stanley
New York
-$25 -1,146 Closed

CMRAW Hedge Fund Activity: Q4 2023 in Review

3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) for Q4 2023, worth a combined $615 — down 97% from $24.3K a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CMRAW and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Clear Street, adding an estimated $2. The largest seller was Warberg Asset Management, exiting entirely with an estimated $6.51K sold.

  • 3 institutional investors held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) as of Q4 2023, down from 15 in Q3 2023.
  • Funds reported $615 of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 stock for Q4 2023, down 97% quarter-over-quarter.
  • 0 funds opened new Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 positions in Q4 2023 and 11 closed out, a net change of -11 holders.
  • The largest Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 buyer in Q4 2023 was Clear Street, an estimated $2 added.
  • The largest Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 seller in Q4 2023 was Warberg Asset Management, an estimated $6.51K sold.

Based on aggregated 13F filings for Q4 2023.